Ultimately, whether AMG 133 can overcome the challenges to achieve success, let us wait and see.
The FDA has approved Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, when used with a reduced-calorie diet and increased physical activity
If you have all of the above, expect a few hours from Hell
In a clinical study, Contrave reduced about 8% of body weight in participants after 56 weeks
cardiovascular risk-reduction indication)
Beyond emergency use, NAC supports liver health in people with: Its anti-inflammatory and antioxidant effects help the liver process toxins, reduce fibrosis, and improve cellular repair